Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
On the contrary, studies in animal models of IBD suggest that the use of DPP-IV inhibitors decreases disease activity
Lancet 392:15191529 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydn L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T (2019) REWIND Investigators
For patients with established atherosclerotic cardiovascular disease, injectable agents with proven outcome data may still be preferred
Glickman and Shapiro explain
US$ 24.24
US$ 28.37
US$ 29.31
US$ 26.06
US$ 28.10
US$ 21.29
US$ 29.94
US$ 29.43
US$ 20.50
US$ 21.03
US$ 26.79
